| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |